OrganiGram Holdings Inc

Healthcare US OGI

1.51USD
0.07(4.86%)

Last update at 2026-03-11T20:06:00Z

Day Range

1.451.52
LowHigh

52 Week Range

0.972.91
LowHigh

Fundamentals

  • Previous Close 1.44
  • Market Cap182.87M
  • Volume602203
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-25.36523M
  • Revenue TTM149.21M
  • Revenue Per Share TTM1.83
  • Gross Profit TTM 35.07M
  • Diluted EPS TTM-1.77

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Income before tax -14.37100M -130.70400M -146.62800M -5.87500M 27.78M
Minority interest - - - - 0.00000M
Net income -14.28300M -132.54600M -136.15700M -9.50400M 20.51M
Selling general administrative 42.35M 30.72M 29.94M 26.67M 9.27M
Selling and marketing expenses 16.86M 15.81M 16.53M 14.62M 6.30M
Gross profit 31.57M -28.39900M -56.49000M 48.47M 52.50M
Reconciled depreciation 24.91M 31.03M 17.96M 8.90M 3.53M
Ebit -38.75200M -91.82000M -145.51000M 5.49M 36.42M
Ebitda -15.20900M -42.92400M -81.08500M 13.74M 39.94M
Depreciation and amortization 23.54M 48.90M 64.42M 8.25M 3.53M
Non operating income net other - - - - -
Operating income -38.75200M -91.82000M -145.51000M 5.49M 36.42M
Other operating expenses 184.56M 152.00M 184.65M 74.31M 23.99M
Interest expense 0.43M 2.96M 6.01M 9.67M 10.09M
Tax provision -0.08800M 0.00000M -10.47100M 3.63M 5.65M
Interest income - - - 10.27M 8.64M
Net interest income -0.42900M -2.96000M -6.00800M -9.66800M -10.09400M
Extraordinary items - - - -0.03800M -1.61100M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -0.08800M 1.84M -10.47100M 3.63M 5.65M
Total revenue 145.81M 79.16M 86.80M 80.41M 12.43M
Total operating expenses 70.32M 44.44M 41.37M 42.37M 16.08M
Cost of revenue 114.24M 107.56M 143.28M 31.94M -40.07000M
Total other income expense net 24.38M -38.88400M -1.11800M -11.36200M 1.46M
Discontinued operations - - - -0.03800M -1.61100M
Net income from continuing ops -14.28300M -130.70400M -136.15700M -9.50400M 22.12M
Net income applicable to common shares -14.28300M -130.70400M -136.15700M -9.54200M 20.51M
Preferred stock and other adjustments - - - - -
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Total assets 298.45M 577.11M 554.02M 417.62M 428.52M
Intangible assets 10.62M 14.26M 2.73M 1.77M 1.50M
Earning assets - - - - -
Other current assets 11.00M 8.36M 6.96M 23.72M 20.65M
Total liab 26.83M 69.05M 74.21M 118.10M 101.52M
Total stockholder equity 271.62M 508.06M 479.81M 299.53M 327.01M
Deferred long term liab 0.39M 0.03M 0.00700M 0.70M 0.59M
Other current liab 1.24M 13.43M 2.75M -11.59500M 40.35M
Common stock 776.91M 769.73M 730.80M 420.67M 318.12M
Capital stock - 769.73M 730.80M 420.67M 318.12M
Retained earnings -538.52800M -289.92700M -275.64400M -144.94000M -8.78300M
Other liab 0.77M 11.40M 43.06M 0.23M 11.59M
Good will - 41.98M 14.32M - -
Other assets 0.00000M 33.14M 35.39M 8.73M 0.59M
Cash 33.86M 68.52M 55.37M 24.60M 47.55M
Cash and equivalents - - - - -
Total current liabilities 22.43M 55.28M 26.27M 29.08M 43.86M
Current deferred revenue 0.09M - - - -
Net debt -29.14500M -65.15800M -50.40400M 79.07M 2.02M
Short term debt 1.09M 1.00M 0.08M 11.60M 3.51M
Short long term debt - 0.08M 0.08M 11.60M 3.51M
Short long term debt total 4.72M 3.36M 4.96M 103.67M 49.58M
Other stockholder equity 33.24M 28.26M 24.72M 23.74M 17.71M
Property plant equipment 99.05M 259.82M 235.94M 247.42M 218.47M
Total current assets 155.98M 221.62M 260.62M 170.20M 196.28M
Long term investments - 7.07M 6.11M 7.00M 11.11M
Net tangible assets 261.00M 451.82M 462.76M 297.75M 324.93M
Short term investments - 30.40M 128.48M 50.13M 0.38M
Net receivables 30.16M 46.07M 21.00M 16.98M 17.45M
Long term debt - 0.15M 0.23M 103.67M 46.07M
Inventory 80.95M 68.28M 48.82M 71.76M 113.80M
Accounts payable 20.01M 40.86M 23.44M 29.08M 40.35M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 33.24M 28.26M 24.65M 23.79M -0.04300M
Additional paid in capital - - - - -
Common stock total equity - - - 420.67M 318.12M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.61M 32.36M 31.11M 8.03M 0.59M
Deferred long term asset charges - - - - -
Non current assets total 142.48M 355.48M 293.40M 247.42M 232.24M
Capital lease obligations - 3.12M 4.65M 2.62M -
Long term debt total - - - - 46.07M
Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Investments 95.47M -72.48700M -138.19600M -46.78200M -97.99700M
Change to liabilities 12.15M 2.06M -27.99500M 10.56M 3.98M
Total cashflows from investing activities 44.03M -115.10900M -138.19600M -46.78200M -97.99700M
Net borrowings -1.01300M -116.40300M 64.05M 47.43M 114.77M
Total cash from financing activities 5.33M 174.46M 160.37M 74.33M 163.91M
Change to operating activities 1.21M -0.54200M 9.60M -13.54000M -2.16900M
Net income -14.28300M -130.70400M -136.15700M -9.50400M 22.12M
Change in cash 13.15M 30.77M -22.95500M -7.50900M 53.11M
Begin period cash flow 55.37M 24.60M 47.55M 55.06M 1.96M
End period cash flow 68.52M 55.37M 24.60M 47.55M 55.06M
Total cash from operating activities -36.21100M -28.58900M -45.12500M -35.08100M -12.70400M
Issuance of capital stock 0.00000M 284.88M 100.00M - 57.50M
Depreciation 24.91M 31.03M 17.96M 8.90M 3.53M
Other cashflows from investing activities 5.78M -30.32700M -7.60700M 1.64M 1.42M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -12.21800M 28.68M 45.64M -40.90900M -48.68400M
Change to account receivables -24.02000M -6.00700M 1.79M -13.13400M 0.34M
Sale purchase of stock - - - 35.15M 64.17M
Other cashflows from financing activities 6.34M 5.99M 61.32M 87.00M 106.80M
Change to netincome -23.95800M 46.08M 44.04M 22.58M 9.79M
Capital expenditures 48.78M 12.33M 78.65M 110.29M 56.44M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -22.87700M 24.20M 29.04M -57.02100M -40.88100M
Stock based compensation 5.13M 3.90M 7.80M 14.89M 5.03M
Other non cash items -28.99700M 0.78M 46.71M 4.01M -0.64300M
Free cash flow -84.98900M -40.91800M -123.77800M -145.37500M -69.13900M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OGI
OrganiGram Holdings Inc
0.07 4.86% 1.51 - 28.99 1.35 1.06 1.06 -0.8728
ZTS
Zoetis Inc
-0.7 0.58% 119.79 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.09 0.35% 25.66 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-3.634 2.72% 130.15 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
-0.09 0.49% 18.12 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OrganiGram Holdings Inc

145 King Street West, Toronto, ON, Canada, M5H 1J8

Key Executives

Name Title Year Born
Ms. Nathalie Batten VP of Operations NA
Mr. Derrick W. West CPA, CPA, (CA) Chief Financial Officer 1967
Ms. Helen Martin Chief Legal Officer & Corp. Sec. 1978
Mr. Gregory Engel Special Advisor 1965
Mr. Timothy Emberg Chief Revenue Officer NA
Mr. Paolo De Luca C.A., C.F.A Chief Strategy Officer 1973
Ms. Beena G. Goldenberg CEO & Director 1963
Mr. Geoff Riggs Chief Information Officer NA
Amy Schwalm VP of Investor Relations NA
Ms. Megan Amber McCrae Sr. VP of Marketing & Communications NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.